Company
Talis Biomedical Corp (0001584751)
Standardized SEC financial data for Talis Biomedical Corp — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001584751 · Laboratory Analytical Instruments.
Gross margin
98.1%
Operating margin
-1000.0%
Net margin
-1000.0%
Revenue growth (YoY)
-55.6%
Return on equity
-89.7%
Free cash flow
-$53.7M
Current ratio
8.86×
EPS (diluted)
$-34.12
Ratios for fiscal year 2023, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|
| Revenue | — | $8.2M | $4.8M | $2.1M |
| Cost of revenue | — | $0 | $8.4M | $41K |
Balance sheet
| USD | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Cash & equivalents | $21.6M | $173.1M | $233.3M | $132.0M | $78.3M |
| Total current assets | — | $188.7M |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|
| Operating cash flow | -$87.0M | -$171.4M | -$100.1M | -$53.2M |
| Capital expenditures | $8.2M | $2.9M | $1.6M | $486K |
Get 0001584751 data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/0001584751/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/0001584751/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"